Cerberus Ventures3 min read
Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data
Vitroscope, a biotech company developing perfusion platforms to study immune activity, treatment responses and disease mechanisms in real time, has raised $7 million, comprising a $5 million seed roun...
By Cate LawrenceTech.eu

Read the full story
Originally published by Tech.eu on Nov 3, 2026.
Comments
Sign in to join the discussion.